Badman, Michael K <br/><br/>
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel Non-Bile Acid FXR Agonist Tropifexor (LJN452) in Healthy Volunteers.  [electronic resource] 

 -  Clinical pharmacology in drug development  04 2020 
 - 395-410 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2160-7648 
<br/><br/><label>Standard No.: </label>10.1002/cpdd.762  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adult<br/>Benzothiazoles--administration & dosage<br/>Diet, High-Fat<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Fasting<br/>Female<br/>Food-Drug Interactions<br/>Half-Life<br/>Humans<br/>Isoxazoles--administration & dosage<br/>Lipids--blood<br/>Male<br/>Middle Aged<br/>Receptors, Cytoplasmic and Nuclear--agonists<br/>Young Adult